Impact of Corticosteroid Treatment and Antiviral Therapy on Clinical Outcomes in Hematopoietic Cell Transplant Patients Infected with Influenza Virus
Open Access
- 1 July 2011
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 17 (7) , 979-986
- https://doi.org/10.1016/j.bbmt.2010.09.014
Abstract
No abstract availableKeywords
Funding Information
- NIH (CA18029, CA15704, HL93294)
- Sanofi Pasteur Vaccines, Novartis, MedImmune, Inc., and Adamas, Pharmaceuticals Inc
- Roche Pharmaceuticals, Glaxo-SmithKline, and Adamas Pharmaceuticals
This publication has 35 references indexed in Scilit:
- The challenge of respiratory virus infections in hematopoietic cell transplant recipientsBritish Journal of Haematology, 2008
- Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantationExpert Opinion on Investigational Drugs, 2007
- Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infectionBlood, 2007
- Corticosteroids for acute bacterial meningitisPublished by Wiley ,2007
- Respiratory Viral Infections in Adults With Hematologic Malignancies and Human Stem Cell Transplantation RecipientsMedicine, 2006
- Comparison of Real-Time PCR Assays with Fluorescent-Antibody Assays for Diagnosis of Respiratory Virus Infections in ChildrenJournal of Clinical Microbiology, 2006
- Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infectionPublished by Wiley ,2005
- Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cellsRespiratory Research, 2005
- Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human InfluenzaJAMA, 1999
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus InfectionsNew England Journal of Medicine, 1997